Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
The company announces new mass spectrometry instruments, workflows, software and industry collaborations during ASMS 2022 Conference MINNEAPOLIS–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, is showcasing new instruments, workflows, software and industry collaborations that enable customers to generate new analytical insights and accelerate next generation vaccine and therapy development. The... Read more